Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Active Not Recruiting NCT05416333

Azelaic Acid as a Novel Treatment for Central Centrifugal Cicatricial Alopecia (CCCA)

Conditions: Central Centrifugal Cicatricial Alopecia

Sex: Female

Ages: 18 Years – N/A

Healthy volunteers: No

Phase: EARLY_PHASE1

Enrollment: 18

Sponsor: Wake Forest University Health Sciences

Location: Wake Forest University Health Scieces Winston-Salem North Carolina

Summary

The purpose of this pilot study is to determine if azelaic acid shows potential to be an effective treatment for Central Centrifugal Cicatricial Alopecia (CCCA). In this study, the aim is to compare azelaic acid vs placebo since azelaic acid may increase anti-inflammatory effects that affect the hair growth cycle.

Eligibility Criteria

Inclusion Criteria: * women eighteen years of age or older * biopsy-proven and /or clinical diagnosis of CCCA Stage II-IV * on stable treatment without changes for at least three months * recruited from outpatient dermatology clinics at the Wake Forest Baptist Health Department of Dermatology Exclusion Criteria: * males

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05416333). StuddyBuddy aggregates publicly available trial information.